TAK-259 hydrochloride
TAK-259 hydrochloride is an orally active α1D-adrenergic receptor antagonist with a Ki value of 1.1 nM for human α1D-adrenergic receptors. TAK-259 hydrochloride can inhibit the contraction of isolated bladder strips in rats with bladder outlet obstruction, reduce non-voiding bladder contractions, and improve urinary frequency symptoms. TAK-259 hydrochloride can be used in research related to overactive bladder.
For research use only. We do not sell to patients.
- CAS No.: 1192347-42-4
- Formula: C14H14Cl3N3O3S
- Molecular Weight:410.70
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Adrenergic Receptor Isoforms
More
Biological Activity
|
Alpha-1D adrenergic receptor 1.1 nM (Ki) |
TAK-259 (Compound 9u) (60 min) hydrochloride potently binds to human α1D-adrenergic receptor in a cell membrane-free binding assay, with a Ki value of 1.1 nM[1].
TAK-259 (10 μM; 5 min at 32°C) hydrochloride exhibits low inhibitory activity against hERG K+ channels in cell-based patch-clamp assays (16% inhibition at 10 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
TAK-259 (10 µg/kg; p.o.) hydrochloride reduces micturition frequency in Cyclophosphamide (HY-17420)-induced cystitis rats when administered at the minimum effective dose of 10 µg/kg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Rats[1]
-
Dosage:10 µg/kg
-
Administration:p.o.
-
Result:Increased voiding intervals, representing the minimum effective dose for reducing urinary frequency in this model.
Chemical Information
-
CAS No. 1192347-42-4
-
Molecular Weight 410.70
-
Formula C14H14Cl3N3O3S
-
SMILES
O=C(N)C1=CC(Cl)=CN(C1=N)CC2=CC(Cl)=CC=C2S(=O)(C)=O.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Sakauchi N, et al. Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities. J Med Chem. 2016 Apr 14;59(7):2989-3002. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)